Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2006
04/18/2006US7029892 nucleic acids coding this enzyme; genetic engineering; isolated polpeptide; insertion vector
04/18/2006US7029891 α1,3-fucosyltransferase
04/18/2006US7029890 Tyrosylprotein sulfotransferases and methods of use thereof
04/18/2006US7029886 Detecting microorganisms using enzyme substrate
04/18/2006US7029882 Suspension for determining sequence of genetic materials, method of determining the sequence of genetic materials by using same, and method for high-speed scoring SNPs
04/18/2006US7029877 binding protease thrombin to phosphoethanolamine binding protein
04/18/2006US7029869 Feeding assay for identifying nematicidal compounds
04/18/2006US7029868 Cell fusion assays using fluorescence resonance energy transfer
04/18/2006US7029865 Nucleotide sequences coding G-protein coupled receptors (MC-4R) for treating obesity and eating disorders
04/18/2006US7029864 Antibody against cleavage product of vimentin
04/18/2006US7029863 Determining cell cholesterol efflux of serum or isolated lipoprotein; obtain cell sample, incubate with scavenger, expose to binding proteins, measure concentration of cholesterol protein
04/18/2006US7029861 detection mutants; drug screening; stimulant tumor necrosis factor;
04/18/2006US7029858 Genetic engineering; binding collagen to integrins; vaccine
04/18/2006US7029855 Radioactive multiplexing analytical methods for biomarkers discovery
04/18/2006US7029854 Methods designing multiple mRNA transcript nucleic acid probe sequences for use in nucleic acid arrays
04/18/2006US7029853 Nucleotide sequences for detection of Bacillus anthracis
04/18/2006US7029852 Biosensors/receptors; for detecting chemical and biological weapons; photocells
04/18/2006US7029851 Polynucleotide encoding a gene conferring resistance to Bacillus thuringiensis toxins
04/18/2006US7029850 Detection variations in molecules attached to surface of oscillating detector driven by networl analyzer
04/18/2006US7029849 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension
04/18/2006US7029848 High throughput screening of gene function using libraries for functional genomics applications
04/18/2006US7029847 Detection dimerizing test polypeptide; obtain population of genetically engineered cells, express vector, isolate cells expressing desired concentration of reporter molecule
04/18/2006US7029846 Site-specific protein modification
04/18/2006US7029845 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
04/18/2006US7029843 Method for the quantitative detection of nucleic acids
04/18/2006US7029842 Detecting and isolating preferential nucleotide sequences from library; obtain library nucleotide sequences, insert vector into nucleotide sequences, transform cell, screen for reporter molecules, detect signal, recover sequences
04/18/2006US7029841 Generation of sensor apparatus; obtain electrode circuit board, form thin film over circuit board, electrodes and transducing element, recover sensor
04/18/2006US7029840 Inhibiting proteolytic enzymes in urine/blood samples by binding trace elements, reducing degradation of cell walls
04/18/2006US7029689 Tubular construct for implantation
04/18/2006CA2485055A1 In situ dilution of external controls for use in microarrays
04/18/2006CA2407353C Biosensor
04/18/2006CA2244768C Polymeric fluorophores enhanced by moieties providing a hydrophobic and conformationally restrictive microenvironment
04/18/2006CA2231880C Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig
04/18/2006CA2133946C Silanes for the surface coating of dielectric materials
04/18/2006CA2129933C Viscosity probe
04/13/2006WO2006039717A2 Methods of determining precise herg interactions and altering compounds based on said interactions
04/13/2006WO2006039697A2 Method of improving drugs with anti-retroviral and anti-cancer activity
04/13/2006WO2006039678A2 Establishment of highly metastatic cell lines using nog mice
04/13/2006WO2006039676A2 Method of identifying inhibitors of viral multiplication eukaryotic cells
04/13/2006WO2006039673A2 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
04/13/2006WO2006039671A2 Gene markers of tumor metastasis
04/13/2006WO2006039564A2 Assay for detecting and quantifying hiv-1
04/13/2006WO2006039563A2 Method for providing dna fragments derived from an archived sample
04/13/2006WO2006039405A2 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof
04/13/2006WO2006039396A2 Non-embedded tissue microarray technology for protein and nucleic acid analyses
04/13/2006WO2006039190A2 System and method for image analysis of slides
04/13/2006WO2006039078A2 Reporter constructs and viral fitness assays
04/13/2006WO2006038955A2 Novel therapeutic targets in cancer
04/13/2006WO2006038908A2 Ancestral and cot viral sequences, proteins and immunogenic compositions
04/13/2006WO2006038794A2 Pmmov resistant capsium plants
04/13/2006WO2006038729A1 Mutated amyloid protein
04/13/2006WO2006038686A1 Gene detection method and gene detection apparatus
04/13/2006WO2006038684A1 Method of screening transmembrane enzyme inhibitory substance
04/13/2006WO2006038673A1 Thermostable or thermoactive dna polymerase and dna coding for the same
04/13/2006WO2006038149A1 Method and apparatus for the detection of labeling elements in a sample
04/13/2006WO2006038037A2 Improvements in induced heteroduplex generators
04/13/2006WO2006038010A2 Detection of breast cancer
04/13/2006WO2006037994A2 Egfr mutations altering the response to erbb receptor drugs
04/13/2006WO2006037617A1 Assay for cytochrome p450 isoforms 3a4 and 3a5
04/13/2006WO2006037611A2 Methods for the early diagnosis of viral infections, inflammatory diseases, a predisposition for proliferative disorders or hyperplasia by analysing eag or erg expression levels
04/13/2006WO2006037563A1 Improved electrophoretic separation method for analyzing gene expression
04/13/2006WO2006037513A1 Diagnostics and therapeutics for diseases associated with matrix metalloproteinase 9 (mmp9)
04/13/2006WO2006037485A2 Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
04/13/2006WO2006018849A3 Non-invasive prenatal genetic diagnosis using transcervical cells
04/13/2006WO2006010515A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)
04/13/2006WO2006008267A3 Methods for optimizing forming viiia-based hemostatic treatment
04/13/2006WO2006008002A3 Diagnostics and therapeutics for diseases associated with kallikrein 1 (klk1)
04/13/2006WO2005123950A3 Perfused three-dimensional cell/tissue disease models
04/13/2006WO2005123942A3 Analysis of methylated nucleic acid
04/13/2006WO2005121799A3 Non-covalent complexes comprising carbon nanotubes
04/13/2006WO2005121374A3 Molecular analysis of hair follicles for disease
04/13/2006WO2005121372A3 Double strand compositions comprising differentially modified strands for use in gene modulation
04/13/2006WO2005118879A3 Identification of tumors
04/13/2006WO2005118832A3 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
04/13/2006WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders
04/13/2006WO2005116255A3 Aptamer-toxin molecules and method for using same
04/13/2006WO2005114574A3 System for the detection and the quantification of exogenous dna of animal origin in edible flours
04/13/2006WO2005112997A3 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues
04/13/2006WO2005111235A3 Methods for detecting chromosome aberrations
04/13/2006WO2005111232A3 Silencing of tumor-suppressive genes by cpg-methylation in prostate cancer
04/13/2006WO2005108620A3 Processing polynucleotide-containing samples
04/13/2006WO2005108604A3 Device and method for detecting molecular interactions
04/13/2006WO2005106022A3 Method of selecting sunflower genotypes with high oleic acid content in seed oil
04/13/2006WO2005095651A3 Molecular markers of cisplatin resistance in cancer and uses thereof
04/13/2006WO2005095644A3 Method for recognizing signatures in complex gene expression profiles
04/13/2006WO2005095632A3 Methods for identifying proteins with starch phosphorylating enzymatic activity
04/13/2006WO2005090602A3 Method for diagnosing or predicting susceptibility to optic nueropathy
04/13/2006WO2005083118A3 Pin-prc transition genes
04/13/2006WO2005078134A3 Gene profiling of human embryonic stem cells
04/13/2006WO2005059692A3 Processing and managing genetic information
04/13/2006WO2005051319A3 Plks as modifiers of the beta catenin pathway and methods of use
04/13/2006WO2005042759A3 Expression profiling using microarrays
04/13/2006WO2005028662A3 Test strip and method for determining ldl cholesterol concentration from whole blood
04/13/2006WO2005026377A3 Detection of nucleic acid sequences
04/13/2006WO2005014850A3 Systems and methods for analyzing nucleic acid sequences
04/13/2006WO2005012876A3 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity
04/13/2006WO2004019882A3 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
04/13/2006WO2003104404A3 Cancer-linked gene as target for chemotherapy
04/13/2006US20060080744 Novel chemokine-like polypeptides
04/13/2006US20060080042 Method of non-targeted complex sample analysis